Article
Haplotype phasing of <i>CYP2D6</i> : an allelic ratio method using Agena MassARRAY data
2023-03-01
Abstract excerpt
Pharmacogenomics aims to use the genetic information of an individual to personalize drug prescribing. There is evidence that pharmacogenomic testing before prescription may prevent adverse drug reactions, increase efficacy, and reduce cost of treatment. CYP2D6 is a key pharmacogene of relevance to multiple therapeutic areas. Indeed, there are prescribing guidelines available for medications based on CYP2D6 enzym...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- ba484006-5bd2-51e2-8973-b9e02cb11689
- DOI
- 10.1101/2023.02.27.530342
